Trine Ahlgreen
Chief Executive Officer
Trine Ahlgreen is an experienced life sciences executive with a strong track record in commercial strategy, product launches, and business development across pharma and biotech.
Trine previously held senior roles at Novo Nordisk A/S, where she led several major launches including Ozempic® and Rybelsus®, and contributed to global and regional strategies across Europe, the US, and Japan. Most recently, at Micreos Pharmaceuticals AG, she built the commercial and BD functions and expanded dermatology partnerships across pharma and OTC sectors.
Known for her collaborative style and strategic mindset, Trine is passionate about building high-performing teams and delivering innovative, patient-centric solutions.